Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
复制标题
DOI:
10.4049/jimmunol.181.4.2277
复制
发表时间:
2008-08-15
期刊:
影响因子:
--
通讯作者:
Kuchroo VK
中科院分区:
文献类型:
--
作者:
Xiao S;Jin H;Korn T;Liu SM;Oukka M;Lim B;Kuchroo VK
The de novo generation of Foxp3+ regulatory T (Treg) cells in the peripheral immune compartment and the differentiation of Th17 cells both require TGF-β, and IL-6 and IL-21 are switch factors that drive the development of Th17 cells at the expense of Treg generation. The major vitamin A metabolite all-trans retinoic acid (RA) not only enforces the generation of Treg but also inhibits the differentiation of Th17 cells. Here we show that RA enhances TGF-β signaling by increasing the expression and phosphorylation of Smad3 and this results in increased Foxp3 expression even in the presence of IL-6 or IL-21. RA also inhibits the expression of IL-6Rα, IRF-4 and IL-23R and thus inhibits Th17 development. In vitro, RA significantly promotes Treg conversion but in vivo during the development of experimental autoimmune encephalomyelitis (EAE) it does not increase the frequency of Treg cells in the face of an ongoing inflammation. However, RA suppresses the disease very efficiently by inhibiting proinflammatory T cell responses, especially pathogenic Th17 responses. These data not only identify the signaling mechanisms by which RA can affect both Treg and Th17 differentiation, but also highlight that in vivo during an autoimmune reaction, RA suppresses autoimmunity mainly by inhibiting the generation of effector Th17 cells. Disclaimer: This is an author-produced version of a manuscript accepted for publication in The Journal of Immunology (The JI). The American Association of Immunologists, Inc. (AAI), publisher of The JI, holds the copyright to this manuscript. This manuscript has not yet been copyedited or subjected to editorial proofreading by The JI; hence it may differ from the final version published in The JI (online and in print). AAI (The JI) is not liable for errors or omissions in this author-produced version of the manuscript or in any version derived from it by the United States National Institutes of Health or any other third party. The final, citable version of record can be found at www.jimmunol.org.
登录
查看更多内容
影响因子:
82.9
作者:
Korn, Thomas;Reddy, Jayagopala;Kuchroo, Vijay K.
通讯作者:
Kuchroo, Vijay K.
影响因子:
56.9
作者:
Mucida, Daniel;Park, Yunji;Cheroutre, Hilde
通讯作者:
Cheroutre, Hilde
影响因子:
19.6
作者:
de Lema, GP;Lucio-Cazaña, FJ;Schlöndorff, D
通讯作者:
Schlöndorff, D
影响因子:
8.6
作者:
Nozaki, Yuji;Yamagata, Toshiaki;Funauchi, Masanori
通讯作者:
Funauchi, Masanori
影响因子:
30.5
作者:
Bruestle, Anne;Heink, Sylvia;Lohoff, Michael
通讯作者:
Lohoff, Michael